Dietary n−6 and n−3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention

Lichtenstein, 2006, Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee, Circulation, 114, 82, 10.1161/CIRCULATIONAHA.106.176158 World Cancer Research Fund / American Institute for Cancer Research, 2007 U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2005 Sanders, 2000, Polyunsaturated fatty acids in the food chain in Europe, Am J Clin Nutr, 71, 176S, 10.1093/ajcn/71.1.176s Das, 2006, Essential fatty acids – a review, Curr Pharm Biotechnol, 7, 467, 10.2174/138920106779116856 Wallis, 2002, Polyunsaturated fatty acid synthesis: what will they think of next?, Trends Biochem Sci, 27, 467, 10.1016/S0968-0004(02)02168-0 Kris-Etherton, 2003, Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, Arterioscler Thromb Vasc Biol, 23, e20, 10.1161/01.ATV.0000038493.65177.94 Surette, 2008, The science behind dietary omega-3 fatty acids, Can Med Assoc J, 178, 177, 10.1503/cmaj.071356 Yen, 2008, Linoleic acid metabolite levels and transepidermal water loss in children with atopic dermatitis, Ann Allergy Asthma Immunol, 100, 66, 10.1016/S1081-1206(10)60407-3 Ziboh, 2000, Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites, Am J Clin Nutr, 71, S361, 10.1093/ajcn/71.1.361s Kim, 2007, Novel metabolism of docosahexaenoic acid in neural cells, J Biol Chem, 282, 18661, 10.1074/jbc.R700015200 Stoffel, 2008, Delta6-desaturase (FADS2) deficiency unveils the role of omega3- and omega6-polyunsaturated fatty acids, EMBO J, 10.1038/emboj.2008.156 Burdge, 2006, Metabolism of alpha-linolenic acid in humans, Prostaglandins Leukot Essent Fatty Acids, 75, 161, 10.1016/j.plefa.2006.05.013 Kaminskas, 1999, Adipose tissue fatty acids in men from two populations with different cardiovascular risk: the LiVicordia study, Scand J Clin Lab Invest, 59, 227, 10.1080/00365519950185751 Mohrhauer, 1967, Chain elongation of linoleic acid and its inhibition by other fatty acids in vitro, J Biol Chem, 242, 4507, 10.1016/S0021-9258(18)99567-0 Benatti, 2004, Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties, J Am Coll Nutr, 23, 281, 10.1080/07315724.2004.10719371 Jump, 1999, Regulation of gene expression by dietary fat, Annu Rev Nutr, 19, 63, 10.1146/annurev.nutr.19.1.63 Pereira, 2004, Identification of two novel microalgal enzymes involved in the conversion of the omega3-fatty acid, eicosapentaenoic acid, into docosahexaenoic acid, Biochem J, 384, 357, 10.1042/BJ20040970 Sprecher, 1999, Polyunsaturated fatty acid biosynthesis: a microsomal-peroxisomal process, Prostaglandins Leukot Essent Fatty Acids, 60, 317, 10.1016/S0952-3278(99)80006-4 Zhou, 2006, Vitamin A deficiency enhances docosahexaenoic and osbond acids in liver of rats fed an alpha linolenic acid-adequate diet, Lipids, 41, 213, 10.1007/s11745-006-5090-x Tocher, 2001, Effects of essential fatty acid deficiency and supplementation with docosahexaenoic acid (DHA; 22 6n−3) on cellular fatty acid compositions and fatty acyl desaturation in a cell culture model, Prostaglandins Leukot Essent Fatty Acids, 64, 11, 10.1054/plef.2000.0233 Das, 2005, A defect in the activity of Delta6 and Delta5 desaturases may be a factor predisposing to the development of insulin resistance syndrome, Prostaglandins Leukot Essent Fatty Acids, 72, 343, 10.1016/j.plefa.2005.01.002 Stulnig, 2001, Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition, J Biol Chem, 276, 37335, 10.1074/jbc.M106193200 Jump, 2002, The biochemistry of n−3 polyunsaturated fatty acids, J Biol Chem, 277, 8755, 10.1074/jbc.R100062200 Levin, 2002, Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2, Biochem J, 365, 489, 10.1042/bj20011798 Weylandt, 2007, Lipoxins and resolvins in inflammatory bowel disease, Inflamm Bowel Dis, 13, 797, 10.1002/ibd.20109 Schmitz, 2008, The opposing effects of n−3 and n−6 fatty acids, Prog Lipid Res, 47, 147, 10.1016/j.plipres.2007.12.004 Sprecher, 2000, Metabolism of highly unsaturated n−3 and n−6 fatty acids, Biochim Biophys Acta, 1486, 219, 10.1016/S1388-1981(00)00077-9 Desvergne, 1999, Peroxisome proliferator-activated receptors: nuclear control of metabolism, Endocr Rev, 20, 649 Coleman, 2004, Enzymes of triacylglycerol synthesis and their regulation, Prog Lipid Res, 43, 134, 10.1016/S0163-7827(03)00051-1 Yoshikawa, 2003, Mol Endocrinol, 17, 1240, 10.1210/me.2002-0190 Ide, 2003, Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling, Mol Endocrinol, 17, 1255, 10.1210/me.2002-0191 Sinclair, 1956, Deficiency of essential fatty acids and atherosclerosis, etcetera, Lancet, 270, 381 Dyerberg, 1975, Fatty acid composition of the plasma lipids in Greenland Eskimos, Am J Clin Nutr, 28, 958, 10.1093/ajcn/28.9.958 Lee, 2003, The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease, QJM, 96, 465, 10.1093/qjmed/hcg092 Holub, 2002, Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care, Can Med Assoc J, 166, 608 Menotti, 1999, Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. The Seven Countries Study Research Group, Eur J Epidemiol, 15, 507, 10.1023/A:1007529206050 Das, 2000, Beneficial effect(s) of n−3 fatty acids in cardiovascular diseases: but, why and how?, Prostaglandins Leukot Essent Fatty Acids, 63, 351, 10.1054/plef.2000.0226 Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Dietary supplementation with n−3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447–55. Hu, 2001, Types of dietary fat and risk of coronary heart disease: a critical review, J Am Coll Nutr, 20, 5, 10.1080/07315724.2001.10719008 Harris, 2006, Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease, Am J Cardiol, 98, 19i, 10.1016/j.amjcard.2005.12.023 Burr, 1989, Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART), Lancet, 2, 757, 10.1016/S0140-6736(89)90828-3 Marchioli, 2002, Early protection against sudden death by n−3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione, Circulation, 105, 1897, 10.1161/01.CIR.0000014682.14181.F2 de Lorgeril, 1999, Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study, Circulation, 99, 779, 10.1161/01.CIR.99.6.779 Singh, 1992, Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up, Br Med J, 304, 1015, 10.1136/bmj.304.6833.1015 Singh, 1997, Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival—4, Cardiovasc Drugs Ther, 11, 485, 10.1023/A:1007757724505 Demaison, 2002, Dietary n−3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action, Cell Mol Life Sci, 59, 463, 10.1007/s00018-002-8439-1 Lee, 2006, Current clinical applications of omega-6 and omega-3 fatty acids, Nutr Clin Pract, 21, 323, 10.1177/0115426506021004323 Louheranta, 1996, Linoleic acid intake and susceptibility of very-low-density and low density lipoproteins to oxidation in men, Am J Clin Nutr, 63, 698, 10.1093/ajcn/63.5.698 Suzukawa, 1995, Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages, J Lipid Res, 36, 473, 10.1016/S0022-2275(20)39881-3 Heller, 2003, Fish or chips?, News Physiol Sci, 18, 50 Bordet, 1988, Hydroperoxides produced by n−6 lipoxygenation of arachidonic and linoleic acids potentiate synthesis of prostacyclin related compounds, Biochim Biophys Acta, 958, 460, 10.1016/0005-2760(88)90232-9 Ascherio, 1996, Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States, Br Med J, 313, 84, 10.1136/bmj.313.7049.84 Hu, 1997, Dietary fat intake and the risk of coronary heart disease in women, N Engl J Med, 337, 1491, 10.1056/NEJM199711203372102 Shekelle, 1981, Diet, serum cholesterol, and death from coronary heart disease: The Western Electric study, N Engl J Med, 304, 65, 10.1056/NEJM198101083040201 Harris, 2006, The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses, Curr Atheroscler Rep, 8, 453, 10.1007/s11883-006-0019-7 Harris, 2007, Tissue n−3 and n−6 fatty acids and risk for coronary heart disease events, Atherosclerosis, 193, 1, 10.1016/j.atherosclerosis.2007.03.018 Wijendran, 2004, Dietary n−6 and n−3 fatty acid balance and cardiovascular health, Annu Rev Nutr, 24, 597, 10.1146/annurev.nutr.24.012003.132106 Svensson, 2000, Progesterone receptor-mediated inhibition of apoptosis in granulosa cells isolated from rats treated with human chorionic gonadotropin, Biol Reprod, 63, 1457, 10.1095/biolreprod63.5.1457 Simopoulos, 1991, Omega-3 fatty acids in health and disease and in growth and development, Am J Clin Nutr, 54, 438, 10.1093/ajcn/54.3.438 Simopoulos, 2002, The importance of the ratio of omega-6/omega-3 essential fatty acids, Biomed Pharmacother, 56, 365, 10.1016/S0753-3322(02)00253-6 Simopoulos, 2006, Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases, Biomed Pharmacother, 60, 502, 10.1016/j.biopha.2006.07.080 de Lorgeril, 1994, Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease, Lancet, 343, 1454, 10.1016/S0140-6736(94)92580-1 Ambring, 2006, Mediterranean-inspired diet lowers the ratio of serum phospholipid n−6 to n−3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects, Am J Clin Nutr, 83, 575, 10.1093/ajcn.83.3.575 Bartram, 1993, Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects, Gastroenterology, 105, 1317, 10.1016/0016-5085(93)90135-Y Kang, 2003, The importance of omega-6/omega-3 fatty acid ratio in cell function. The gene transfer of omega-3 fatty acid desaturase, World Rev Nutr Diet, 92, 23, 10.1159/000073790 Kang, 2004, Transgenic mice: fat-1 mice convert n−6 to n−3 fatty acids, Nature, 427, 504, 10.1038/427504a von Schacky, 2007, Cardiovascular benefits of omega-3 fatty acids, Cardiovasc Res, 73, 310, 10.1016/j.cardiores.2006.08.019 De Backer, 2003, European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice, Eur Heart J, 24, 1601, 10.1016/S0195-668X(03)00347-6 Smith, 2006, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute, Circulation, 113, 2363, 10.1161/CIRCULATIONAHA.106.174516 Hooper, 2006, Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review, Br Med J, 332, 752, 10.1136/bmj.38755.366331.2F Food, 2005 Kris-Etherton, 2000, Polyunsaturated fatty acids in the food chain in the United States, Am J Clin Nutr, 71, S179, 10.1093/ajcn/71.1.179S MacLean, 2006, Effects of omega-3 fatty acids on cancer risk: a systematic review, J Am Med Assoc, 295, 403, 10.1001/jama.295.4.403